US Patent Litigations are now available. Check here

IP Verse

E R Squibb & Sons patent opposition analysis

Latest patents of E R Squibb & Sons opposed by its competitors

Explore E R Squibb & Sons's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 26, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3597216Aug 24, 2022Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses Thereof5
EP2905030Nov 6, 2019Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses Thereof1
EP2439273Feb 27, 2019Human Monoclonal Antibodies To Programmed Death 1(Pd-1) And Methods For Treating Cancer Using Anti-Pd-1 Antibodies Alone Or In Combination With Other Immunotherapeutics1
EP2501822Aug 16, 2017Methods For Enhanced Protein Production2